Showing results (371-380 of 408) with videos related to
Sort By:
Pageof 41
Leukemia|May 15, 2015
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemiaJ Khalife, H S Radomska, R Santhanam, et al.Journal of Physical Activity & Health|June 8, 2023
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After VaccinationFabiana Infante Smaira, Bruna Caruso Mazzolani, Ítalo Ribeiro Lemes, et al.International Journal of Environmental Research and Public Health|October 26, 2024
Massive Education in Prison Health in Brazil: A Look Beyond the WallsJanaina L R da S Valentim, Sara Dias-Trindade, Aline de P Dias, et al.The Lancet. HIV|March 26, 2022
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort studyLucas C Netto, Karim Y Ibrahim, Camila M Picone, et al.Genome Announcements|November 8, 2014
Genomic Sequence of the Yeast Kluyveromyces marxianus CCT 7735 (UFV-3), a Highly Lactose-Fermenting Yeast Isolated from the Brazilian Dairy IndustryWendel B Silveira, Raphael H S Diniz, M Esperanza Cerdán, et al.Biological Psychiatry Global Open Science|June 12, 2025
High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant DepressionStephen A Murata, Zachary B Madaj, Colt D Capan, et al.Lupus|May 20, 2022
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndromeFlavio Signorelli, Gustavo Guimarães Moreira Balbi, Nadia E Aikawa, et al.Rheumatology (Oxford, England)|October 19, 2021
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2Samuel K Shinjo, Fernando H C de Souza, Isabela B P Borges, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patientsBruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 12, 2012
Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013Kenneth C Anderson, Melissa Alsina, William Bensinger, et al.Pageof 41